The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 25, 2022
Filed:
Oct. 24, 2017
Applicant:
Callion Pharma, Llc, Jonesborough, TN (US);
Inventor:
Konstantinos Andreas Papas, Jonesborough, TN (US);
Assignee:
Callion Pharma, LLC, Jonesborough, TN (US);
Primary Examiner:
Int. Cl.
CPC ...
A23L 33/155 (2016.01); A23L 29/00 (2016.01); A23L 33/105 (2016.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/07 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/59 (2006.01); A61K 31/592 (2006.01); A61K 31/122 (2006.01); A61K 33/04 (2006.01); A61K 31/455 (2006.01); A61P 3/02 (2006.01); A61K 31/519 (2006.01); A61K 31/525 (2006.01); A61K 31/714 (2006.01); A61K 31/4188 (2006.01); A61K 31/065 (2006.01); A61K 31/593 (2006.01); A61K 31/51 (2006.01); A61K 31/4415 (2006.01); A61K 31/01 (2006.01); A61K 31/047 (2006.01); A61K 31/197 (2006.01); A61K 33/30 (2006.01);
U.S. Cl.
CPC ...
A23L 33/155 (2016.08); A23L 29/045 (2016.08); A23L 29/055 (2016.08); A23L 33/105 (2016.08); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 31/01 (2013.01); A61K 31/047 (2013.01); A61K 31/065 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/197 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/59 (2013.01); A61K 31/592 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/04 (2013.01); A61K 33/30 (2013.01); A61P 3/02 (2018.01); A23V 2002/00 (2013.01); A23V 2200/314 (2013.01); A23V 2250/1626 (2013.01); A23V 2250/1642 (2013.01); A23V 2250/211 (2013.01); A23V 2250/213 (2013.01); A23V 2250/314 (2013.01); A23V 2250/702 (2013.01); A23V 2250/705 (2013.01); A23V 2250/708 (2013.01); A23V 2250/7046 (2013.01); A23V 2250/7052 (2013.01); A23V 2250/7056 (2013.01); A23V 2250/71 (2013.01); A23V 2250/712 (2013.01); A23V 2250/714 (2013.01); A23V 2250/72 (2013.01);
Abstract
Provided herein are antioxidant-enriched multivitamin compositions comprising vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, thiamin, riboflavin, niacin, vitamin B6, folic acid, vitamin B 12, biotin, pantothenic acid, zinc, selenium, coenzyme Q10, lutein, lycopene, and zeaxanthin for the treatment of fat malabsorption diseases such as cystic fibrosis. Also provided are methods of treating vitamin and micronutrient deficiencies in subjects suffering from cystic fibrosis by administering an antioxidant-enriched multivitamin composition.